New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 31, 2013
06:56 EDTQDELQuidel 501(k) clearance shows management's ability, says William Blair
William Blair views Quidel's 501(k) clearance for its AmpliVue Group B Strep Assay as another example of managementís ability to get products through the FDA. The firm says it does not expect a significant ramp-up in 2014 for the product as this is a new market for Quidel. William Blair sees meaningful upside potential for the stock should management continue to execute and keeps an Outperform rating on the name.
News For QDEL From The Last 14 Days
Check below for free stories on QDEL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for QDEL

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use